Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|September 6, 2017
Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic AstrocytomaJennifer Clarke, Elizabeth Neil, Robert Terziev, et al.
Journal of Neurosurgery|December 15, 2010
Impact of bevacizumab chemotherapy on craniotomy wound healingAaron J Clark, Nicholas A Butowski, Susan M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone proteinCourtney A Crane, Seunggu J Han, Brian Ahn, et al.
Experimental Neurology|December 9, 2008
Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A diseaseJames C Dodge, Jennifer Clarke, Christopher M Treleaven, et al.
Journal of Proteome Research|May 8, 2012
Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brainsVictor P Andreev, Vladislav A Petyuk, Heather M Brewer, et al.
Neuro-Oncology|March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy modelsS Pablo Sardi, Catherine Viel, Jennifer Clarke, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2005
Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A diseaseJames C Dodge, Jennifer Clarke, Antonius Song, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2013
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathiesS Pablo Sardi, Jennifer Clarke, Catherine Viel, et al.
Pageof 17